On March 13, 2019, 170 leaders from across the country and the health care spectrum came together to discuss strategies for tackling some of the industry’s most relevant challenges at our 13th annual Summit.

Dr. A. Mark Fendrick, V-BID Center director, delivered the welcoming remarks to kick off Wednesday’s panel discussions.  The day-long summit consisted of 4 interactive sessions:

Surprise Announcement!

Daniel Carey, Virginia secretary of Health and Human Resources, announced the launch of a new statewide pilot in Virginia designed to reduce the use of low-value care.  Read More

Panelists:

  • Mark Atalla, Center for Medicare and Medicaid Services
  • Melanie Egorin, U.S. House Ways and Means Committee
  • Stephen Parente, University of Minnesota
Moderator:
  • Cliff Goodman, Lewin Group
V-BID 2.0 icon, turquoise circle, graphic

Taking place only a few months after the Centers for Medicare and Medicaid Services announced transformative updates to the Medicare Advantage Value-Based Insurance Design (MA-VBID) Model, this session served as a platform to discuss the potential impact of the V-BID 2.0 Model.  Launching in 2020 and running through 2024, this expanded model will test a wide range of MA service delivery and/or payment approaches in an effort to lower costs, while increasing the quality and coverage of care for Medicare beneficiaries.  In anticipation of this nation-wide expansion, speakers Atalla, Egorin, and Parente shared their uniquely informed insights, leading to a conversation that engaged a variety of perspectives from across the healthcare spectrum.

Panelists:

  • Daniel Carey, Commonwealth of Virginia
  • Gwen Darien, National Patient Advocate Foundation
  • John Keats, Cigna
Moderator:
  • Cliff Goodman, Lewin Group

The concept of value is a well-known topic among health policy experts, the payer community, and policy makers, but patients do not necessarily have the same idea of what value means. When discussions about removing low-value care from the system to save money come up, patients might get the wrong idea of what is going on and why. Read More

Panelists:

  • Daniel Klein, PAN Foundation
  • Ted Okon, Community Oncology Alliance
Moderator:
  • Cliff Goodman, Lewin Group

Access to affordable prescription drugs is a topic of increasing public concern. In a recent survey, 82% of respondents identified medical costs as their biggest financial challenge. In this session, panelists Okon and Klein focus on the necessity of addressing cost burden on patients. Read More

Drug prices are clearly important, but from our perspective as a safety net provider, we are faced, day to day, with patients calling us who can’t afford to start their treatment or to stay on their treatment,

Panelists:

  • Michael Chernew, Harvard Medical School
  • Greg Gierer, America’s Health Insurance Plans (AHIP)
  • Lourdes Grindal Miller, Centers for Medicare and Medicaid Services
Moderator:
  • Cliff Goodman, Lewin Group

Value-based insurance design (V-BID) aligns patient cost sharing with the value of clinical services, so that patients pay less for high-value services and more for unnecessary, low-value services. While there has been increased interest in VBID, with CMS expanding the VBID demonstration in Medicare Advantage to all 50 states, the situation on the state exchanges is different: The plan has to be cost neutral, so in order to remove cost sharing for high-value services, cost sharing has to increase for other, low-value services. In this session, panelists discussed the process of coming up with “V-BID X” – a market-qualified health plan that implements V-BID proposals. Read More

Thank You To Our Sponsors!